PRIA Logo™
119-s-5554119th CongressWALLET

Ovarian Cancer IMPACT Act

Sponsored By: Senator Slotkin, Elissa [D-MI]

Introduced

Summary

Expanding access to genetic testing and specialty ovarian cancer care. This bill reauthorizes and modernizes Johanna's Law to boost outreach and education about ovarian and hereditary cancer risk and creates federal standards requiring coverage of genetic counseling, testing, and risk‑reducing services.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

3 provisions identified: 3 benefits, 0 costs, 0 mixed.

More coverage for hereditary ovarian risk

This bill would require group and individual health plans to cover genetic counseling, multi-gene germline testing, targeted mutation testing, tumor genomic/biomarker testing, and guideline-recommended risk-reducing care for people who meet the rules. Eligible people would include those with a personal history of ovarian cancer, people with endometrial cancer when guidelines recommend testing, and people with family histories indicating hereditary ovarian or related cancer syndromes. The coverage rules would apply to plan years beginning one year after enactment and would also apply to grandfathered group health plans. The bill would not force anyone to get testing or procedures.

Grants to boost ovarian cancer outreach

If enacted, the bill would expand the national ovarian cancer outreach campaign and fund demonstration grants to test outreach and access strategies. It would authorize $20 million per year for each fiscal year 2027 through 2031 for outreach, education, and demonstration projects. Grants and materials would prioritize culturally and linguistically appropriate outreach and give preference to projects serving rural, medically underserved, Tribal, or high-risk populations. Grant projects would report outcomes within three years of awards and annually after that.

Training for providers on genetic testing

The bill would direct HHS, through the CDC Director and in consultation with HRSA, to support activities that increase health care professionals' awareness of evidence-based genetic counseling and testing guidelines for ovarian and endometrial cancer. Activities would also cover collecting family cancer history, referral pathways for genetic counseling and specialty care, and the proposed coverage protections. The provision specifies no funding amount.

Sponsors & CoSponsors

Sponsor

Slotkin, Elissa [D-MI]

MI • D

Cosponsors

  • Sen. Britt, Katie Boyd [R-AL]

    AL • R

    Sponsored 9/24/2026

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation